메뉴 건너뛰기




Volumn 60, Issue 17, 2000, Pages 4819-4824

Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VATALANIB;

EID: 0034282515     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (315)

References (21)
  • 4
    • 0022648938 scopus 로고
    • How is blood vessel growth regulated in normal and neoplastic tissue?
    • (1986) Cancer Res. , vol.46 , pp. 467-476
    • Folkman, J.1
  • 5
    • 0029679536 scopus 로고    scopus 로고
    • Tumor angiogenesis. The pivotal role of vascular endothelial growth factor (VEGF)
    • (1996) World J. Urol. , vol.14 , pp. 166-174
    • Marme, D.1
  • 7
    • 0022622802 scopus 로고
    • Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes
    • (1986) Cancer Res. , vol.46 , pp. 3358-3363
    • Salup, R.R.1    Wiltrout, R.H.2
  • 18
    • 0002581222 scopus 로고    scopus 로고
    • New anti-angiogenesis agents: Review of the clinical experience with carboxyamido-triazole, thalidomide, TNP-470 and interleukin-12
    • (1997) Angiogenesis , vol.1 , pp. 23-35
    • Masiero, L.1    Figg, W.D.2    Kohn, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.